Our global capabilities enable end-to-end development of potential treatments.
Janssen Research & Development’s Neuroscience team has comprehensive scientific expertise in the development of transformative treatments for neuropsychiatric and neurodegenerative diseases. Global clinical research capabilities for end-to-end development of potential treatments give us the flexibility to grow strong relationships. We continue to build our presence in Asia Pacific, Latin America, Europe, the Middle East and emerging markets by establishing R&D activities and expanding our sales and marketing operations.
Our Neuroscience team is also pioneering holistic “predict and pre-empt” paradigms that involve early diagnostics, patient adherence tools, digital therapy for cognitive remediation, remote monitoring for relapse prediction and patient management programs.